Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...

Moderna ($MRNA) steps into Thursday’s analyst day with more pressure than momentum. The stock is down more than 40% this year ...

Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the February 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

Fintel reports that on November 21, 2025, Leerink Partners maintained coverage of Moderna (NasdaqGS:MRNA) with a Underperform ...

Moderna ( (MRNA)) has provided an update. On November 12, 2025, Moderna, Inc. held a Special Meeting of Shareholders where two proposals were approved. The first was a one-time stock option exchange ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BeOne Medicines (ONC – Research Report), Moderna (MRNA – Research Report) and ...

Telemark Asset Management, LLC established a new position in Moderna ( MRNA +1.10%), acquiring 500,000 shares valued at approximately $12.91 million as of September 30, 2025, according to a November ...

Merck rebounds on pipeline wins and a $9.2B Cidara deal, but mixed trends and Keytruda risks keep investors weighing next moves.

Boston-based Moderna has been the S&P 500’s most shorted stock since the end of September, according to S3 Partners. Short ...